Abstract
Carbapenemase-producing enterobacteriaceae (CPE) are the Gram-negative bacilli that this type of carbapenemic hydrolysis enzymes most often carry. In particular, Klebsiella pneumoniae is the most common. The carbapenemases KPC, VIM, NDM, IMP, and OXA-48 are the most common. They are usually acquired in a nosocomial setting and are associated with healthcare (time of hospitalization; ICU stay; prior antibiotic therapy; comorbidity; use of vascular catheters, bladder catheters, mechanical ventilation, etc.). They produce symptoms similar those caused by enterobacteriaceae, with urinary tract infections (UTIs) those that have the best prognosis and bacteremias and pneumonias those with greater associated mortality. Antibiotic treatments available include colistin, aminoglycosides, fosfomycin, aztreonam, and tigecycline. Carbapenems can also be used so long as the minimum inhibitory concentration (MIC) allows for them; their combined use is preferred. New available drugs include ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, plazomicin, cefiderocol, and eravacycline.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Medicine - Programa de Formación Médica Continuada acreditado
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.